Infect Chemother.  2011 Apr;43(2):178-185. 10.3947/ic.2011.43.2.178.

Foot and Mouth Disease : Etiology, Epidemiology and Control Measures

• Yoo HS

• KMID: 1782358
• DOI: http://doi.org/10.3947/ic.2011.43.2.178

Abstract

Foot and mouth disease (FMD) is highly infectious disease of cloven-hoofed animals, particularly cattle, sheep, pigs and goats. Also, it is the most important animal pathogen on the global scale because of the potential for rapid and extensive spread through susceptible animal populations. Outbreak can lead to formidable economic consequence for domestic livestock production and international trade. FMD is caused by FMD virus which is a small, non-enveloped, positive-sense RNA virus belonging to the genus Aphthovirus within the family Picornaviridae . There are seven immunologically distinct serotypes; O, A, C, SAT (Southern African Territories) 1, SAT 2, SAT 3 and Asia 1 and a diverse antigenic spectrum of virus strains within each serotype. Characteristic lesion of FMD is the formation of vesicles in the mucosal membranes of mouth, muzzle, foot, and teats. Nowadays, many developed countries have maintained FMD-free as a result of eradication efforts. However, outbreaks of FMD have occurred in several countries, even in Europe, and it is still endemic in Africa, the Middle East, Asia, and South America. Last year, three outbreaks of FMD occurred in our country. Last outbreak reported in November, 2010 induced the enormous social and economical impacts. Culling of infected animals, movement control, and vaccination are the major control measures of FMD. To control the disease, each country has their own strategies based on the current situation of FMD in their country. Therefore, I would like to discuss the causative agent, epidemiological properties and control measures of FMD in this paper.

Keyword

Foot and mouth disease; Agent; Epidemiology; Control

MeSH Terms

Africa
Animals
Aphthovirus
Asia
Cattle
Communicable Diseases
Developed Countries
Disease Outbreaks
Europe
Foot
Foot-and-Mouth Disease
Goats
Humans
Livestock
Membranes
Middle East
Mouth
Picornaviridae
RNA Viruses
Sheep
South America
Swine
Vaccination
Viruses

Reference

1. Berentsen PBM, Dijkhuizen AA, Oskam AJ. A dynamic model for cost-benefit analyses of foot-and-mouth disease control strategies. Prev Vet Med. 1992. 12:229–243.

2. Garner MG, Lack MB. An evaluation of alternate control strategies for foot-and-mouth disease in Australia - a regional approach. Prev Vet Med. 1995. 23:9–32.

3. Krystynak RH, Charlebois PA. The potential economic impact of an outbreak of foot-and-mouth disease in Canada. Can Vet J. 1987. 28:523–527.

4. Mahul O, Durand B. Simulated economic consequences of foot-and-mouth disease epidemics and their public control in France. Prev Vet Med. 2000. 47:23–38.

5. Mahul O, Gohin A. Irreversible decision making in contagious animal disease control under uncertainty: an illustration using FMD in Brittany. Eur Rev Agric Econ. 1999. 26:39–58.

6. Belsham GJ. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol. 1993. 60:241–260.

7. Sobrino F, Sáiz M, Jiménez-Clavero MA, Núñez JI, Rosas MF, Baranowski E, Ley V. Foot-and-mouth disease: a long known virus, but a current threat. Vet Res. 2001. 32:1–30.

8. Ministry for Food, Agriculture, Forestry and Fisheries. An foot-and-mouth disease white book. 2003. Anyang: National Veterinary Research & Quarantine Service.

9. Bae Yuchan, Yun Sunsik, Bak Jungwon, Jin Yeonghwa. [Gungnae balsaeng gujeyeok mit gujeyeok yusajilbyeong dogam]. 2003. Anyang: National Veterinary Research & Quarantine Service, MAF.

10. Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev. 2004. 17:465–493.

11. Alexandersen S, Zhang Z, Donaldson AI, Garland AJ. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol. 2003. 129:1–36.

12. Bachrach HL, Breese SS Jr, Callis JJ, Hess WR, Patty RE. Inactivation of foot-and-mouth disease virus by pH and temperature changes and by formaldehyde. Proc Soc Exp Biol Med. 1957. 95:147–152.

13. Pharo HJ. Foot-and-mouth disease: an assessment of the risks facing New Zealand. N Z Vet J. 2002. 50:46–55.

14. Chou CC, Yang SE. Inactivation and degradation of O Taiwan97 foot-and-mouth disease virus in pork sausage processing. Food Microbiol. 2004. 21:737–742.

15. Cottral GE, Cox BF, Baldwin DE. The survival of foot-and-mouth disease virus in cured and uncured meat. Am J Vet Res. 1960. 21:288–297.

16. Park JH, Lee KN, Kim SM, Ko YJ, Lee HS, Cho IS. Resistance of foot-and-mouth disease virus in various environments. Korean J Vet Public Health. 2009. 33:197–204.

17. Park JH, Lee KN, Kim SM, Ko YJ, Lee HS, Heo EJ, Kweon CH, Yang CB. The condition for air-borne transmission of foot-and-mouth disease. Korean J Vet Public Health. 2008. 32:205–212.

18. United States Department of Agriculture (USDA). Foot and mouth disease: Sources of outbreaks and hazard categorization of modes of virus transmission. 1994. Fort Collins, CO: USDA, APHIS, VS.

19. Wijnker JJ, Haas B, Berends BR. Removal of foot-and-mouth disease virus infectivity in salted natural casings by minor adaptation of standardized industrial procedures. Int J Food Microbiol. 2007. 115:214–219.

20. Morris CA. A review of genetic resistance to disease in Bos taurus cattle. Vet J. 2007. 174:481–491.

21. Kaleta EF. Foot-and-mouth disease: susceptibility of domestic poultry and free-living birds to infection and to disease--a review of the historical and current literature concerning the role of birds in spread of foot-and-mouth disease viruses. Dtsch Tierarztl Wochenschr. 2002. 109:391–399.

22. Donaldson AI, Alexandersen S. Relative resistance of pigs to infection by natural aerosols of FMD virus. Vet Rec. 2001. 148:600–602.

23. Donaldson AI, Gibson CF, Oliver R, Hamblin C, Kitching RP. Infection of cattle by airborne foot-and-mouth disease virus: minimal doses with O1 and SAT 2 strains. Res Vet Sci. 1987. 43:339–346.

24. Sellers RF. Quantitative aspects of the spread of foot and mouth disease. Vet Bull. 1971. 41:431–439.

25. Donaldson AI, Alexandersen S, Sørensen JH, Mikkelsen T. Relative risks of the uncontrollable (airborne) spread of FMD by different species. Vet Rec. 2001. 148:602–604.

26. Kitching RP, Alexandersen S. Clinical variation in foot and mouth disease: pigs. Rev Sci Tech. 2002. 21:513–518.

27. Kitching RP. Clinical variation in foot and mouth disease: cattle. Rev Sci Tech. 2002. 21:499–504.

28. Sanson RL. The epidemiology of foot-and-mouth disease: implications for New Zealand. N Z Vet J. 1994. 42:41–53.

29. Davies G. Foot and mouth disease. Res Vet Sci. 2002. 73:195–199.

30. World Organisation for Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. 2008. 6th ed. Paris: Office international des epizooties.

31. Cox SJ, Barnett PV. Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review. Vet Res. 2009. 40:13.

32. Ryan E, Mackay D, Donaldson A. Foot-and-mouth disease virus concentrations in products of animal origin. Transbound Emerg Dis. 2008. 55:89–98.

33. Timoney JF, Gillespie JH, Scott FW, Barlough JE, editors. Foot and mouth disease. Hagan and Bruner's microbiology and infectious diseases of domestic animals. 1988. 8th ed. New York: Cornell University Press;647–667.

34. Gloster J, Jones A, Redington A, Burgin L, Sørensen JH, Turner R, Dillon M, Hullinger P, Simpson M, Astrup P, Garner G, Stewart P, D'Amours R, Sellers R, Paton D. Airborne spread of foot-and-mouth disease-model intercomparison. Vet J. 2010. 183:278–286.

35. Lee SH, Jong MH, Huang TS, Lin YL, Wong ML, Liu CI, Chang TJ. Pathology and viral distributions of the porcinophilic foot-and-mouth disease virus strain (O/Taiwan/97) in experimentally infected pigs. Transbound Emerg Dis. 2009. 56:189–201.

36. Sutmoller P, Barteling SS, Olascoaga RC, Sumption KJ. Control and eradication of foot-and-mouth disease. Virus Res. 2003. 91:101–144.

37. Thomson GR, Vosloo W, Bastos ADS. Dodet B, Vicari M, editors. The epidemiology and control of foot-and-mouth disease in sub-Saharan Africa. Foot-and-mouth disease: control strategies. 2003. Paris: Elsevier;125–134.

38. McVicar JW, Sutmoller P. Growth of foot-and-mouth disease virus in the upper respiratory tract of non-immunized, vaccinated, and recovered cattle after intranasal inoculation. J Hyg (Lond). 1976. 76:467–481.

39. Cox BF, Cottral GE, Baldwin E. Further studies on the survival of foot-and-mouth disease virus in meat. Am J Vet Res. 1961. 22:224.

40. Burrows R. Excretion of foot-and-mouth disease virus prior to the development of lesions. Vet Rec. 1968. 82:387–388.

41. Sellers RF, Burrows R, Mann JA, Dawe P. Recovery of virus from bulls affected with foot-and-mouth disease. Vet Rec. 1968. 83:303.

42. Burrows R, Mann JA, Garland AJ, Greig A, Goodridge D. The pathogenesis of natural and simulated natural foot-and-mouth disease infection in cattle. J Comp Pathol. 1981. 91:599–609.

43. Sutmoller P. Importation of beef from countries infected with foot and mouth disease: a review of risk mitigation measures. Rev Sci Tech. 2001. 20:715–722.

44. Hutber AM, Kitching RP, Conway DA. Predicting the level of herd infection for outbreaks of foot-and-mouth disease in vaccinated herds. Epidemiol Infect. 1999. 122:539–544.

45. Kitching RP. Identification of foot and mouth disease virus carrier and subclinically infected animals and differentiation from vaccinated animals. Rev Sci Tech. 2002. 21:531–538.

46. Kitching RP. Future research on foot and mouth disease. Rev Sci Tech. 2002. 21:885–889.

47. Paton DJ, Sinclair M, Rodríguez R. Qualitative assessment of the commodity risk for spread of foot-and-mouth disease associated with international trade in deboned beef. Transbound Emerg Dis. 2010. 57:115–134.

48. Alexandersen S, Zhang Z, Donaldson AI. Aspects of the persistence of foot-and-mouth disease virus in animals--the carrier problem. Microbes Infect. 2002. 4:1099–1110.

49. Sutmoller P, Casas OR. Unapparent foot and mouth disease infection (sub-clinical infections and carriers): implications for control. Rev Sci Tech. 2002. 21:519–529.

50. Beard CW, Mason PW. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol. 2000. 74:987–991.

51. Thomson GR. OIE Comprehensive Reports on Technical Items Presented to the International Committee or to Regional Commissions. The role of carriers in the transmission of foot and mouth disease. 1996. 87–103.

52. Sharma SK. Studies on foot and mouth disease in sheep with special reference to distribution of the virus and carrier status. Vet Res Bull. 1978. 1:156–157.

53. Condy JB, Hedger RS, Hamblin C, Barnett IT. The duration of the foot-and-mouth disease virus carrier state in African buffalo (i) in the individual animal and (ii) in a free-living herd. Comp Immunol Microbiol Infect Dis. 1985. 8:259–265.

54. Moonen P, Schrijver R. Carriers of foot-and-mouth disease virus: a review. Vet Q. 2000. 22:193–197.

55. Gibbs EP, Herniman KA, Lawman MJ, Sellers RF. Foot-and-mouth disease in British deer: transmission of virus to cattle, sheep and deer. Vet Rec. 1975. 96:558–563.

56. Bastos AD, Boshoff CI, Keet DF, Bengis RG, Thomson GR. Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa. Epidemiol Infect. 2000. 124:591–598.

57. Alonso A, Martins MA, Gomes Mda P, Allende R, Söndahl MS. Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera. J Vet Diagn Invest. 1992. 4:249–253.

58. Ferris NP, Donaldson AI. The World Reference Laboratory for Foot and Mouth Disease: a review of thirty-three years of activity (1958-1991). Rev Sci Tech. 1992. 11:657–684.

59. Roeder PL, Le Blanc. Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Res Vet Sci. 1987. 43:225–232.

60. Ferris NP, Nordengrahn A, Hutchings GH, Reid SM, King DP, Ebert K, Paton DJ, Kristersson T, Brocchi E, Grazioli S, Merza M. Development and laboratory validation of a lateral flow device for the detection of foot-and-mouth disease virus in clinical samples. J Virol Methods. 2009. 155:10–17.

61. Ferris NP, Dawson M. Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Vet Microbiol. 1988. 16:201–209.

62. Reid SM, Ferris NP, Hutchings GH, Samuel AR, Knowles NJ. Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction. J Virol Methods. 2000. 89:167–176.

63. Reid SM, Grierson SS, Ferris NP, Hutchings GH, Alexandersen S. Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus. J Virol Methods. 2003. 107:129–139.

64. Shaw AE, Reid SM, Ebert K, Hutchings GH, Ferris NP, King DP. Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. J Virol Methods. 2007. 143:81–85.

65. Vangrysperre W, De Clercq K. Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses. Arch Virol. 1996. 141:331–344.

66. Callahan JD, Brown F, Osorio FA, Sur JH, Kramer E, Long GW, Lubroth J, Ellis SJ, Shoulars KS, Gaffney KL, Rock DL, Nelson WM. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J Am Vet Med Assoc. 2002. 220:1636–1642.

67. Golding SM, Hedger RS, Talbot P. Radial immuno-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Res Vet Sci. 1976. 20:142–147.

68. Chénard G, Miedema K, Moonen P, Schrijver RS, Dekker A. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J Virol Methods. 2003. 107:89–98.

69. Mackay DK, Bulut AN, Rendle T, Davidson F, Ferris NP. A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J Virol Methods. 2001. 97:33–48.

70. Paiba GA, Anderson J, Paton DJ, Soldan AW, Alexandersen S, Corteyn M, Wilsden G, Hamblin P, MacKay DK, Donaldson AI. Validation of a foot-and-mouth disease antibody screening solid-phase competition ELISA (SPCE). J Virol Methods. 2004. 115:145–158.

71. Hamblin C, Barnett IT, Hedger RS. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I Development and method of ELISA. J Immunol Methods. 1986. 93:115–121.

72. Hamblin C, Kitching RP, Donaldson AI, Crowther JR, Barnett IT. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III Evaluation of antibodies af ter infection and vaccination. Epidemiol Infect. 1987. 99:733–744.

73. Bergmann IE, Malirat V, Neitzert E, Beck E, Panizzutti N, Sánchez C, Falczuk A. Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay. Arch Virol. 2000. 145:473–489.

74. De Diego M, Brocchi E, Mackay D, De Simone F. The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol. 1997. 142:2021–2033.

75. Mackay DK, Forsyth MA, Davies PR, Berlinzani A, Belsham GJ, Flint M, Ryan MD. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine. 1998. 16:446–459.

76. Sørensen KJ, Madsen KG, Madsen ES, Salt JS, Nqindi J, Mackay DK. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol. 1998. 143:1461–1476.

77. Doel TR, Williams L, Barnett PV. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine. 1994. 12:592–600.

78. Rodriguez LL, Grubman MJ. Foot and mouth disease virus vaccines. Vaccine. 2009. 27:Suppl 4. D90–D94.

79. Capstick PB, Telling RC, Chapman WG, Stewart DL. Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot-and-mouth disease. Nature. 1962. 195:1163–1164.

80. Brown F, Hyslop NS, Crick J, Morrow AW. The use of acetylethyleneimine in the production of inactivated foot-and-mouth disease vaccines. J Hyg (Lond). 1963. 61:337–344.

81. Bahnemann HG. The inactivation of foot-and-mouth disease virus by ethylenimine and propylenimine. Zentralbl Veterinarmed B. 1972. 20:356–360.

82. Doel TR. FMD vaccines. Virus Res. 2003. 91:81–99.

83. Laporte J. The structure of foot-and-mouth disease virus protein. J Gen Virol. 1969. 4:631–634.

84. Rowlands DJ, Sangar DV, Brown F. Relationship of the antigenic structure of foot-and-mouth disease virus to the process of infection. J Gen Virol. 1971. 13:85–93.

85. Bachrach HL, Moore DM, McKercher PD, Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol. 1975. 115:1636–1641.

86. Kleid DG, Yansura D, Small B, Dowbenko D, Moore DM, Grubman MJ, McKercher PD, Morgan DO, Robertson BH, Bachrach HL. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science. 1981. 214:1125–1129.

87. Office International des Epizooties. Foot and mouth disease, Paris, France. World Organisation for Animal Health. Accessed 28 March 2011. Avaiable at: http://www.oie.int.international-standard-setting/terrestrial-code/access-online/.